NCT06376045 A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma Status TERMINATED Phase PHASE2
NCT06360354 A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103) Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06352892 A Study to Evaluate AMG 133 in Chinese Participants With Obesity or Overweight Status COMPLETED Phase PHASE1
NCT06333951 Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104). Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06333678 A Study Comparing Sotorasib With Durvalumab in People With Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT06332014 Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06321601 Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV. Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06312020 A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome Status TERMINATED Phase PHASE2
NCT06311721 A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06295679 A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease Status RECRUITING Phase N/A
NCT06268860 A Study to Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy Participants Status COMPLETED Phase PHASE1
NCT06252649 Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation Status RECRUITING Phase PHASE3
NCT06248619 A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06245408 A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06229145 A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout Status COMPLETED Phase PHASE4
NCT06224192 A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT06214481 A Study to Evaluate Rocatinlimab (AMG 451) in Healthy Chinese Participants Status COMPLETED Phase PHASE1
NCT06211036 Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06207682 Effect of Repeated Oral Doses of Avacopan on the Pharmacokinetics (PK) of a Single Dose of Simvastatin Status COMPLETED Phase PHASE1